 |
|
|
|
|
 |
 |
Childhood Neurotherapeutics Center of Economic Excellence
University collaborators: University of South Carolina (fiscal agent) Medical University of South Carolina (collaborative partner) About the CoEE: The Childhood Neurotherapeutics CoEE uses recent advances in pharmacogenetics, metabolic disorders, and neuroinflammatory diseases to study neurological disorders in children. Research at this CoEE will be particularly focused on preventing brain damage in premature infants (neuroprotection) and curing infant brain diseases through cellular engineering. In collaboration with the Greenville Hospital System, this CoEE operates a statewide team that is developing neural stem cell therapeutic approaches to neurological disorders in children. Neural stem cells have recently been identified as having high repair capacity, particularly during development. This important scientific discovery will allow the CoEE to contribute to the treatment of these disorders and to transfer research knowledge directly to patient application. This CoEE shares an FDA grant with the Philadelphia Children’s Hospital to evaluate the efficacy of atorvastatin for Type I diabetes patients. These studies have resulted in a start-up company, ImmunoMod, which develops drugs for treatment of diabetes. To date, faculty associated with this CoEE have generated more than $3.3 million in research funding.
Funding level: CoEE Endowed Chairs:
|
